FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017788135> ?p ?o ?g. }

• W2017788135 endingPage "341" @default.
• W2017788135 startingPage "333" @default.
• W2017788135 abstract "To study the prognosis of persons with type 1 diabetes in relation to the degree of nephropathy at initiation of intensified insulin therapy.Ten years follow-up of a cohort of 3674 patients who had participated in a 5-day group treatment and teaching programme for intensification of insulin therapy between September 1978 and December 1994.Ten diabetes centres in Germany.A total of 3674 patients (insulin treatment before age 31), age at baseline 27 +/- 10 years, with a diabetes duration of 11 +/- 9 years. Patients were divided into three groups according to baseline renal parameters (group I, normal proteinuria, n = 1829; group II, microproteinuria, n = 1257; group III, at least macroproteinuria, n = 367).End-stage diabetic complications (blindness, amputations, renal replacement therapy, standardized mortality ratios (SMR) and causes of death.Outcome measures were documented for 97% of patients; 251 (7%) had died. During follow-up, 1% of patients in group I, 4% in group II and 47% in group III had at least one end-stage diabetic complication. SMR for men: nephropathy group I, 2.2 (95% CI = 1.5-3); group II, 3.2 (2.3-4.3); group III, 11.5 (8.8-14.7). SMR for women: group I, 2.5 (1.5-3.8); group II, 3.5 (2.2-5.3); group III, 27 (19.8-35.9). Causes of death for men and women combined: group I (total 58 deaths)--cardiovascular, 21 (36%); hypoglycaemia, 1; ketoacidosis, 3; violent deaths, 17 (29%); others, 16; group II (66 deaths)--cardiovascular, 25 (38%); hypoglycaemia, 2; ketoacidosis, 2; violent deaths, 14 (21%); others, 23; group III (114 deaths)--cardiovascular, 68 (60%); hypoglycaemia, 2; ketoacidosis, 5; infections, 15 (13%); violent deaths, 5 (4%); others, 19.Patients with microproteinuria have only a slightly worse prognosis than patients with normal proteinuria during the first 10 years after initiation of intensified insulin therapy. Excess mortality amongst patients who started intensified insulin therapy is mainly due to those with manifest clinical nephropathy." @default.
• W2017788135 created "2016-06-24" @default.
• W2017788135 creator A5002962412 @default.
• W2017788135 creator A5024260220 @default.
• W2017788135 creator A5040271171 @default.
• W2017788135 creator A5050591965 @default.
• W2017788135 creator A5056277495 @default.
• W2017788135 creator A5079778863 @default.
• W2017788135 date "2000-10-01" @default.
• W2017788135 modified "2023-10-15" @default.
• W2017788135 title "Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy" @default.
• W2017788135 cites W1995263671 @default.
• W2017788135 cites W1999165003 @default.
• W2017788135 cites W2013093313 @default.
• W2017788135 cites W2026353630 @default.
• W2017788135 cites W2041294505 @default.
• W2017788135 cites W2041309967 @default.
• W2017788135 cites W2065592823 @default.
• W2017788135 cites W2065745446 @default.
• W2017788135 cites W2066226427 @default.
• W2017788135 cites W2087910275 @default.
• W2017788135 cites W2123595476 @default.
• W2017788135 cites W2128300830 @default.
• W2017788135 cites W2134840843 @default.
• W2017788135 cites W2154384957 @default.
• W2017788135 cites W2166951250 @default.
• W2017788135 cites W2913579954 @default.
• W2017788135 cites W4233271415 @default.
• W2017788135 cites W4245335029 @default.
• W2017788135 cites W4252271922 @default.
• W2017788135 cites W4256166634 @default.
• W2017788135 doi "https://doi.org/10.1046/j.1365-2796.2000.00745.x" @default.
• W2017788135 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11086645" @default.
• W2017788135 hasPublicationYear "2000" @default.
• W2017788135 type Work @default.
• W2017788135 sameAs 2017788135 @default.
• W2017788135 citedByCount "23" @default.
• W2017788135 countsByYear W20177881352012 @default.
• W2017788135 countsByYear W20177881352015 @default.
• W2017788135 countsByYear W20177881352016 @default.
• W2017788135 countsByYear W20177881352018 @default.
• W2017788135 countsByYear W20177881352020 @default.
• W2017788135 crossrefType "journal-article" @default.
• W2017788135 hasAuthorship W2017788135A5002962412 @default.
• W2017788135 hasAuthorship W2017788135A5024260220 @default.
• W2017788135 hasAuthorship W2017788135A5040271171 @default.
• W2017788135 hasAuthorship W2017788135A5050591965 @default.
• W2017788135 hasAuthorship W2017788135A5056277495 @default.
• W2017788135 hasAuthorship W2017788135A5079778863 @default.
• W2017788135 hasBestOaLocation W20177881351 @default.
• W2017788135 hasConcept C126322002 @default.
• W2017788135 hasConcept C134018914 @default.
• W2017788135 hasConcept C141071460 @default.
• W2017788135 hasConcept C2775849729 @default.
• W2017788135 hasConcept C2777180221 @default.
• W2017788135 hasConcept C2779306644 @default.
• W2017788135 hasConcept C2779541074 @default.
• W2017788135 hasConcept C2779561371 @default.
• W2017788135 hasConcept C2780091579 @default.
• W2017788135 hasConcept C2781184683 @default.
• W2017788135 hasConcept C2781232474 @default.
• W2017788135 hasConcept C2781283889 @default.
• W2017788135 hasConcept C555293320 @default.
• W2017788135 hasConcept C71924100 @default.
• W2017788135 hasConcept C72563966 @default.
• W2017788135 hasConcept C81182388 @default.
• W2017788135 hasConceptScore W2017788135C126322002 @default.
• W2017788135 hasConceptScore W2017788135C134018914 @default.
• W2017788135 hasConceptScore W2017788135C141071460 @default.
• W2017788135 hasConceptScore W2017788135C2775849729 @default.
• W2017788135 hasConceptScore W2017788135C2777180221 @default.
• W2017788135 hasConceptScore W2017788135C2779306644 @default.
• W2017788135 hasConceptScore W2017788135C2779541074 @default.
• W2017788135 hasConceptScore W2017788135C2779561371 @default.
• W2017788135 hasConceptScore W2017788135C2780091579 @default.
• W2017788135 hasConceptScore W2017788135C2781184683 @default.
• W2017788135 hasConceptScore W2017788135C2781232474 @default.
• W2017788135 hasConceptScore W2017788135C2781283889 @default.
• W2017788135 hasConceptScore W2017788135C555293320 @default.
• W2017788135 hasConceptScore W2017788135C71924100 @default.
• W2017788135 hasConceptScore W2017788135C72563966 @default.
• W2017788135 hasConceptScore W2017788135C81182388 @default.
• W2017788135 hasIssue "4" @default.
• W2017788135 hasLocation W20177881351 @default.
• W2017788135 hasLocation W20177881352 @default.
• W2017788135 hasOpenAccess W2017788135 @default.
• W2017788135 hasPrimaryLocation W20177881351 @default.
• W2017788135 hasRelatedWork W155406078 @default.
• W2017788135 hasRelatedWork W2017127800 @default.
• W2017788135 hasRelatedWork W2036520486 @default.
• W2017788135 hasRelatedWork W2367972701 @default.
• W2017788135 hasRelatedWork W2611456965 @default.
• W2017788135 hasRelatedWork W2948247360 @default.
• W2017788135 hasRelatedWork W2948859911 @default.
• W2017788135 hasRelatedWork W2977566213 @default.
• W2017788135 hasRelatedWork W3011787927 @default.
• W2017788135 hasRelatedWork W3176974623 @default.
• W2017788135 hasVolume "248" @default.

• next